Search Results - "Smithers, B."

Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations by Low, Donald E., Allum, William, De Manzoni, Giovanni, Ferri, Lorenzo, Immanuel, Arul, Kuppusamy, MadhanKumar, Law, Simon, Lindblad, Mats, Maynard, Nick, Neal, Joseph, Pramesh, C. S., Scott, Mike, Mark Smithers, B., Addor, Valérie, Ljungqvist, Olle

“…Introduction Enhanced recovery after surgery (ERAS) programs provide a format for multidisciplinary care and has been shown to predictably improve short term…”
Get full text

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis by Sjoquist, Katrin M, FRACP, Burmeister, Bryan H, Prof, Smithers, B Mark, Prof, Zalcberg, John R, Prof, Simes, R John, Prof, Barbour, Andrew, FRACS, Gebski, Val, Prof

“…Summary Background In a previous meta-analysis, we identified a survival benefit from neoadjuvant chemotherapy or chemoradiotherapy before surgery in patients…”
Get full text

Quality indicators in surgery for cancer: not just the operation by Smithers, B. Mark

Get full text

Conclusions from quality of life studies in patients with resected high-risk melanoma: one part of the full story by Smithers, B Mark

“…The European Organisation for Research and Treatment of Cancer, Quality of Life Questionnaire–30 (EORTC QLQ-30) instrument was used in the other two adjuvant…”
Get full text

An investigation into the nutritional status of patients receiving an Enhanced Recovery After Surgery (ERAS) protocol versus standard care following Oesophagectomy by Benton, Katie, Thomson, Iain, Isenring, Elisabeth, Mark Smithers, B., Agarwal, Ekta

“…Purpose Enhanced Recovery After Surgery (ERAS) protocols have been effectively expanded to various surgical specialities including oesophagectomy. Despite…”
Get full text

Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995–2014 by Aitken, Joanne F., Youlden, Danny R., Baade, Peter D., Soyer, H. Peter, Green, Adèle C., Smithers, B. Mark

“…Public campaigns encouraging sun protection for skin cancer prevention began in Queensland, Australia, in the early 1980s. We examined recent trends to assess…”
Get full text

Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis by Miura, John T., Kroon, Hidde M., Beasley, Georgia M., Mullen, Dean, Farrow, Norma E., Mosca, Paul J., Lowe, Michael C., Farley, Clara R., Kim, Youngchul, Naqvi, Syeda Mahrukh Hussnain, Potdar, Aishwarya, Daou, Hala, Sun, James, Farma, Jeffrey M., Henderson, Michael A., Speakman, David, Serpell, Jonathan, Delman, Keith A., Mark Smithers, B., Coventry, Brendon J., Tyler, Douglas S., Thompson, John F., Zager, Jonathan S.

“…Background Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose regional chemotherapy to patients with locally advanced or…”
Get full text

TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG by Leong, Trevor, Smithers, B. Mark, Haustermans, Karin, Michael, Michael, Gebski, Val, Miller, Danielle, Zalcberg, John, Boussioutas, Alex, Findlay, Michael, O’Connell, Rachel L., Verghis, Jaclyn, Willis, David, Kron, Tomas, Crain, Melissa, Murray, William K., Lordick, Florian, Swallow, Carol, Darling, Gail, Simes, John, Wong, Rebecca

“…Background Postoperative chemoradiation and perioperative chemotherapy using epirubicin/cisplatin/5-fluorouracil (ECF) represent two standards of care for…”
Get full text

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial by Henderson, Michael A, Prof, Burmeister, Bryan H, Prof, Ainslie, Jill, FRANZCR, Fisher, Richard, PhD, Di Iulio, Juliana, PhD, Smithers, B Mark, Prof, Hong, Angela, PhD, Shannon, Kerwin, FRACS, Scolyer, Richard A, Prof, Carruthers, Scott, FRANZCR, Coventry, Brendon J, Prof, Babington, Scott, FRANZCR, Duprat, Joao, PhD, Hoekstra, Harald J, Prof, Thompson, John F, Prof

“…Summary Background Adjuvant radiotherapy is recommended for patients with melanoma after lymphadenectomy. We previously showed this treatment reduced risk of…”
Get full text

International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG) by Low, Donald E, Alderson, Derek, Cecconello, Ivan, Chang, Andrew C, Darling, Gail E, DʼJourno, Xavier Benoit, Griffin, S Michael, Hölscher, Arnulf H, Hofstetter, Wayne L, Jobe, Blair A, Kitagawa, Yuko, Kucharczuk, John C, Law, Simon Ying Kit, Lerut, Toni E, Maynard, Nick, Pera, Manuel, Peters, Jeffrey H, Pramesh, C S, Reynolds, John V, Smithers, B Mark, van Lanschot, J. Jan B

“…INTRODUCTION:Perioperative complications influence long- and short-term outcomes after esophagectomy. The absence of a standardized system for defining and…”
Get full text

Achieving a textbook outcome in patients undergoing gastric resections in a low incidence, high-volume Australian Upper GI unit by Bouffler, Clare, King, Sarah, Frankel, Adam, Barbour, Andrew, Scott, Justin, Thomas, Janine, Smithers, B. Mark, Thomson, Iain

“…Textbook outcome (TBO) has been proposed as a composite measure of quality in esophagogastric surgery, and achieving a TBO has been associated with improved…”
Get full text

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial by Burmeister, Bryan H, Prof, Henderson, Michael A, Prof, Ainslie, Jill, FRANZCR, Fisher, Richard, PhD, Di Iulio, Juliana, PhD, Smithers, B Mark, FRACS, Hong, Angela, PhD, Shannon, Kerwin, FRACS, Scolyer, Richard A, Prof, Carruthers, Scott, FRANZCR, Coventry, Brendon J, FRACS, Babington, Scott, FRANZCR, Duprat, Joao, Prof, Hoekstra, Harald J, Prof, Thompson, John F, Prof

“…Summary Background The use of radiotherapy after therapeutic lymphadenectomy for patients with melanoma at high risk of further lymph-node field and distant…”
Get full text

TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG) by Leong, Trevor, Smithers, B Mark, Michael, Michael, Gebski, Val, Boussioutas, Alex, Miller, Danielle, Simes, John, Zalcberg, John, Haustermans, Karin, Lordick, Florian, Schuhmacher, Christoph, Swallow, Carol, Darling, Gail, Wong, Rebecca

“…The optimal management of patients with resectable gastric cancer continues to evolve in Western countries. Following publication of the US Intergroup 0116 and…”
Get full text

Patients with in‐transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV‐10—A propensity score matched, single center study by Read, Tavis, Fayers, Warren, Thomas, Janine, Wagels, Michael, Barbour, Andrew, Mark Smithers, B.

“…Background and Objective Isolated limb infusion (ILI) and intralesional PV‐10 are well described locoregional therapies for in‐transit melanoma. The objective…”
Get full text

Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy by M. Naeini, Marjan, Newell, Felicity, Aoude, Lauren G., Bonazzi, Vanessa F., Patel, Kalpana, Lampe, Guy, Koufariotis, Lambros T., Lakis, Vanessa, Addala, Venkateswar, Kondrashova, Olga, Johnston, Rebecca L., Sharma, Sowmya, Brosda, Sandra, Holmes, Oliver, Leonard, Conrad, Wood, Scott, Xu, Qinying, Thomas, Janine, Walpole, Euan, Tao Mai, G., Ackland, Stephen P., Martin, Jarad, Burge, Matthew, Finch, Robert, Karapetis, Christos S., Shannon, Jenny, Nott, Louise, Bohmer, Robert, Wilson, Kate, Barnes, Elizabeth, Zalcberg, John R., Mark Smithers, B., Simes, John, Price, Timothy, Gebski, Val, Nones, Katia, Watson, David I., Pearson, John V., Barbour, Andrew P., Waddell, Nicola

“…Oesophageal adenocarcinoma is a poor prognosis cancer and the molecular features underpinning response to treatment remain unclear. We investigate whole…”
Get full text

Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor by von Schuckmann, Lena A, Hughes, Maria Celia B, Ghiasvand, Reza, Malt, Maryrose, van der Pols, Jolieke C, Beesley, Vanessa L, Khosrotehrani, Kiarash, Smithers, B Mark, Green, Adele C

“…With emerging new systemic treatments for metastatic melanoma, early detection of disease recurrence is increasingly important. To investigate the risk of…”
Get more information

Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma by Morton, Donald L, Thompson, John F, Cochran, Alistair J, Mozzillo, Nicola, Nieweg, Omgo E, Roses, Daniel F, Hoekstra, Harold J, Karakousis, Constantine P, Puleo, Christopher A, Coventry, Brendon J, Kashani-Sabet, Mohammed, Smithers, B. Mark, Paul, Eberhard, Kraybill, William G, McKinnon, J. Gregory, Wang, He-Jing, Elashoff, Robert, Faries, Mark B

“…Sentinel-node biopsy followed by lymphadenectomy for tumor-positive nodes improved disease-free survival among patients with intermediate-thickness melanomas…”
Get full text

Trends and patterns of care of sentinel node biopsy in cutaneous melanoma: a population-based study in Queensland by Wong, Jessica, Moore, Julie, Soyer, H Peter, Mar, Victoria, Smithers, B Mark

“…Sentinel node biopsy (SNB) has evolved from offering staging and prognostication to a procedure that guides therapeutic management. The aim was to evaluate the…”
Get full text

Risk Stratification for Early Esophageal Adenocarcinoma: Analysis of Lymphatic Spread and Prognostic Factors by Barbour, Andrew P., Jones, Mark, Brown, Ian, Gotley, David C., Martin, Ian, Thomas, Janine, Clouston, Andrew, Mark Smithers, B.

“…Background Knowledge of factors related to outcome is vital for the selection of therapeutic alternatives for patients with early (T1) esophageal…”
Get full text

Pulmonary metastasectomy in the era of targeted therapy and immunotherapy by Bong, Christopher Y, Smithers, B Mark, Chua, Terence C

“…Metastatic melanoma is a fatal malignancy with a high mortality and morbidity. Since the early 1970s, available medical therapies were limited in improving…”
Get full text